Temporal Pharmacokinetic/Pharmacodynamic Interaction between Human CD3ε Antigen–Targeted Monoclonal Antibody Otelixizumab and CD3ε Binding and Expression in Human Peripheral Blood Mononuclear Cell Static Culture